Chinese drugmakers have struck a record number of deals this year to sell their assets overseas, sending biotech stocks surging as investors bet the country will become a driving force in global drug discovery.
中國制藥企業今年達成的向海外出售其資產的交易數量創歷史新高，推動生物科技股飆升。投資者押注中國將成為全球藥物研發的一股推動力量。
您已閱讀3%（274字），剩余97%（9350字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。